AHCO — Adapthealth Share Price
Last Trade - 00:00- $3.42bn
- $5.08bn
- $1.36bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.34 | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 529.64 | 1,070.67 | 2,356.09 | 2,678.33 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +37.45 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Adapthealth Corp. is a provider of home healthcare equipment, medical supplies to the home and related services in the United States. The Company is focused on primarily providing sleep therapy equipment, supplies and related services to individuals suffering from obstructive sleep apnea (OSA), home medical equipment (HME) to patients discharged from acute care and other facilities. The Company offers oxygen and related chronic therapy services in the home, and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy and nutritional supply needs. The company is also partners’ with diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The Company services beneficiaries of Medicare, Medicaid and commercial insurance payors and services over approximately 1.6 million patients annually.
Directors
- Richard Barasch NEC (67)
- Joshua Parnes (43)
- Stephen Griggs CEO (63)
- Jason Clemens (43)
- Albert Prast (60)
- Frank Mullen (51)
- Christopher Joyce (57)
- Daniel Bunting (59)
- Shaw Rietkerk OTH (46)
- Terence Connors (66)
- Bradley Coppens (39)
- Theodore Lundberg (46)
- Alan Quasha (71)
- Susan Weaver (60)
- David Williams (48)
- Dale Wolf (67)
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- November 22nd, 2017
- Public Since
- February 16th, 2018
- No. of Shareholders
- 92
- No. of Employees
- 8,700
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 142,463,332
- Address
- 220 W Germantown Pike Ste 250, PLYMOUTH MEETING, 19462
- Web
- Phone
- +1 6106306357
- Auditors
- KPMG LLP
Latest News for AHCO
Upcoming events for AHCO
Q3 2021 Adapthealth Corp Earnings Release
Similar to AHCO
ANTARES PHARMA ORD
NASDAQ Capital Market
BEYOND AIR ORD
NASDAQ Capital Market
BIOLIFE SOLUTIONS ORD
NASDAQ Capital Market
BIOMERICA ORD
NASDAQ Capital Market
DARIOHEALTH ORD
NASDAQ Capital Market
FAQ
As of Today at 19:55 UTC, shares in Adapthealth are trading at $24.00. This share price information is delayed by 15 minutes.
Shares in Adapthealth last closed at $24.00 and the price had moved by +9.49% over the past 365 days. In terms of relative price strength the Adapthealth share price has underperformed the S&P500 Index by -16.93% over the past year.
The overall consensus recommendation for Adapthealth is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Adapthealth does not currently pay a dividend.
Adapthealth does not currently pay a dividend.
Adapthealth does not currently pay a dividend.
To buy shares in Adapthealth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $24.00, shares in Adapthealth had a market capitalisation of $3.42bn.
Here are the trading details for Adapthealth:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AHCO
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Adapthealth does not currently have a style classification.
The analyst consensus target price for shares in Adapthealth is $41.75. That is 73.96% above the last closing price of $24.00.
Analysts covering Adapthealth currently have a consensus Earnings Per Share (EPS) forecast of $1.00 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adapthealth. Over the past six months, its share price has underperformed the S&P500 Index by -34.03%.
As of the last closing price of $24.00, shares in Adapthealth were trading -22.37% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Adapthealth.
Adapthealth's management team is headed by:
- Richard Barasch - NEC
- Joshua Parnes -
- Stephen Griggs - CEO
- Jason Clemens -
- Albert Prast -
- Frank Mullen -
- Christopher Joyce -
- Daniel Bunting -
- Shaw Rietkerk - OTH
- Terence Connors -
- Bradley Coppens -
- Theodore Lundberg -
- Alan Quasha -
- Susan Weaver -
- David Williams -
- Dale Wolf -
We do not have data on Adapthealth's shareholders